专利号:US-2022048879-A1 优先权日:2020-08-13 标 题:Synthesis of small molecules inspired by Phomoxanthone A 发明人:ALI RAMEEZ; MATTSON ANITA 权利人:WORCESTER POLYTECH INST 摘要:Methods, compositions, and kits are provided for synthesizing bioactive chromane, the method including: constructing a tertiary ether stereocenter enantioselectively by catalyzed alkynylation of a substituted chromenone to obtain a chromanone; reducing alkyne and ketone in the chromanone to obtain a chroman; and converting ester to methyl group thereby obtaining chromane.
专利号:US-9168248-B2 优先权日:2009-02-17 标 题:Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase 发明人:LACHANCE NICOLAS; LECLERC JEAN-PHILIPPE; LI CHUN SING; MORADEI OSCAR MIGUEL 权利人:LACHANCE NICOLAS; LECLERC JEAN-PHILIPPE; LI CHUN SING; MORADEI OSCAR MIGUEL; MERCK CANADA INC 摘要:Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.
专利号:WO-2022036040-A1 优先权日:2020-08-13 标 题 :Synthesis of small molecules inspired by phomoxanthone a
专利号:US-2017304168-A1 优先权日:2012-05-11 标题 :Phenyl ketone derivatives as self-tanning agents 发明人:CAROLA CHRISTOPHE 权利人:MERCK PATENT GMBH 摘要:The present invention relates to the use of phenyl ketone derivatives of the formula I for use as self-tanning substance or for increasing melanin synthesis, improving melanin transport and/or improving the distribution of melanin in suprabasal layers, and to preparations comprising these phenyl ketone derivatives.
专利号:RU-2195455-C2 优先权日:1995-04-11 标 题 :Substituted 1-phenyl-3-carboxamides and their pharmaceutically acceptable salts, method of their synthesis, intermediate compounds and pharmaceutical composition based on thereof showing affinity to human neurotensin receptors